Remifentanil for General Anesthesia in Preeclamptics

• Status: Unknown status
• Trial end date: 2009-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to determine whether remifentanil use in preeclamptic patients may blunt hemodynamic response to intubation during general anesthesia for cesarean section.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Istanbul University
• Treatments: Anesthetics; Remifentanil

Criteria

Inclusion Criteria:

• Severe preeclamptic parturients with single fetus pregnancy with contraindication to regional anesthesia

Exclusion Criteria:

• Known allergy to study drugs

• Known fetal anomaly and /or gestation week and /or estimated to be nonviable (fetal weight <400 gr, gestational week<24 weeks)

• Known cardiac disease diagnosed prior to pregnancy

• Known drug abuse in the parturient

• Multifetal gestation

• Anticipated difficult airway management (mask ventilation and/or endotracheal intubation).